vs
Encompass Health Corp（EHC）とFastenal（FAST）の財務データ比較。上の社名をクリックして会社を切り替えられます
Fastenalの直近四半期売上が大きい（$2.0B vs $1.5B、Encompass Health Corpの約1.3倍）。Fastenalの純利益率が高く（14.5% vs 9.5%、差は5.0%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs 3.5%）。Fastenalの直近四半期フリーキャッシュフローが多い（$308.2M vs $116.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs 2.9%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
ファスナル社は1967年設立の米国上場企業で、本社はミネソタ州ウィノナに所在します。北米最大のファスナー流通業者であり、産業・建設用資材の主要供給元として、在庫管理、自動販売機、物流などのサプライチェーンソリューションを提供しています。
EHC vs FAST — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $2.0B |
| 純利益 | $146.1M | $293.9M |
| 粗利率 | — | 44.3% |
| 営業利益率 | 16.7% | 18.9% |
| 純利益率 | 9.5% | 14.5% |
| 売上前年比 | 9.9% | 3.5% |
| 純利益前年比 | 20.8% | -1.6% |
| EPS（希薄化後） | $1.43 | $-0.01 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | — | $2.0B | ||
| Q4 25 | $1.5B | $2.0B | ||
| Q3 25 | $1.5B | $2.1B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.4B | $1.8B | ||
| Q3 24 | $1.4B | $1.9B | ||
| Q2 24 | $1.3B | $1.9B |
| Q1 26 | — | $293.9M | ||
| Q4 25 | $146.1M | $293.9M | ||
| Q3 25 | $126.5M | $335.5M | ||
| Q2 25 | $142.1M | $330.3M | ||
| Q1 25 | $151.5M | $298.7M | ||
| Q4 24 | $120.9M | $262.1M | ||
| Q3 24 | $108.2M | $298.1M | ||
| Q2 24 | $114.1M | $292.7M |
| Q1 26 | — | 44.3% | ||
| Q4 25 | — | 44.3% | ||
| Q3 25 | — | 45.3% | ||
| Q2 25 | — | 45.3% | ||
| Q1 25 | — | 45.1% | ||
| Q4 24 | — | 44.8% | ||
| Q3 24 | — | 44.9% | ||
| Q2 24 | — | 45.1% |
| Q1 26 | — | 18.9% | ||
| Q4 25 | 16.7% | 18.9% | ||
| Q3 25 | 14.9% | 20.7% | ||
| Q2 25 | 16.2% | 21.0% | ||
| Q1 25 | 16.4% | 20.1% | ||
| Q4 24 | 14.3% | 18.9% | ||
| Q3 24 | 13.6% | 20.3% | ||
| Q2 24 | 14.3% | 20.2% |
| Q1 26 | — | 14.5% | ||
| Q4 25 | 9.5% | 14.5% | ||
| Q3 25 | 8.6% | 15.7% | ||
| Q2 25 | 9.7% | 15.9% | ||
| Q1 25 | 10.4% | 15.2% | ||
| Q4 24 | 8.6% | 14.4% | ||
| Q3 24 | 8.0% | 15.6% | ||
| Q2 24 | 8.8% | 15.3% |
| Q1 26 | — | $-0.01 | ||
| Q4 25 | $1.43 | $-0.01 | ||
| Q3 25 | $1.24 | $0.29 | ||
| Q2 25 | $1.39 | $0.29 | ||
| Q1 25 | $1.48 | $0.52 | ||
| Q4 24 | $1.18 | $0.45 | ||
| Q3 24 | $1.06 | $0.52 | ||
| Q2 24 | $1.12 | $0.51 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $276.8M |
| 総負債低いほど良い | $2.4B | $125.0M |
| 株主資本純資産 | $2.4B | $3.9B |
| 総資産 | $7.1B | $5.1B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | 0.03× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | $276.8M | ||
| Q4 25 | $72.2M | $276.8M | ||
| Q3 25 | $48.7M | $288.1M | ||
| Q2 25 | $99.1M | $237.8M | ||
| Q1 25 | $95.8M | $231.8M | ||
| Q4 24 | $85.4M | $255.8M | ||
| Q3 24 | $147.8M | $292.2M | ||
| Q2 24 | $154.4M | $255.5M |
| Q1 26 | — | $125.0M | ||
| Q4 25 | $2.4B | $125.0M | ||
| Q3 25 | $2.4B | $195.0M | ||
| Q2 25 | $2.3B | $230.0M | ||
| Q1 25 | $2.3B | $200.0M | ||
| Q4 24 | $2.4B | $200.0M | ||
| Q3 24 | $2.3B | $240.0M | ||
| Q2 24 | $2.7B | $235.0M |
| Q1 26 | — | $3.9B | ||
| Q4 25 | $2.4B | $3.9B | ||
| Q3 25 | $2.4B | $3.9B | ||
| Q2 25 | $2.3B | $3.8B | ||
| Q1 25 | $2.2B | $3.7B | ||
| Q4 24 | $2.1B | $3.6B | ||
| Q3 24 | $2.0B | $3.6B | ||
| Q2 24 | $1.8B | $3.5B |
| Q1 26 | — | $5.1B | ||
| Q4 25 | $7.1B | $5.1B | ||
| Q3 25 | $6.9B | $5.1B | ||
| Q2 25 | $6.8B | $5.0B | ||
| Q1 25 | $6.6B | $4.9B | ||
| Q4 24 | $6.5B | $4.7B | ||
| Q3 24 | $6.5B | $4.7B | ||
| Q2 24 | $6.4B | $4.6B |
| Q1 26 | — | 0.03× | ||
| Q4 25 | 1.00× | 0.03× | ||
| Q3 25 | 1.01× | 0.05× | ||
| Q2 25 | 1.02× | 0.06× | ||
| Q1 25 | 1.08× | 0.05× | ||
| Q4 24 | 1.14× | 0.06× | ||
| Q3 24 | 1.20× | 0.07× | ||
| Q2 24 | 1.46× | 0.07× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $368.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $308.2M |
| FCFマージンFCF / 売上 | 7.6% | 15.2% |
| 設備投資強度設備投資 / 売上 | 14.8% | 3.0% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | 1.25× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $1.2B |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | $368.2M | ||
| Q4 25 | $346.0M | $368.2M | ||
| Q3 25 | $270.8M | $386.9M | ||
| Q2 25 | $270.2M | $278.6M | ||
| Q1 25 | $288.6M | $262.2M | ||
| Q4 24 | $278.8M | $282.8M | ||
| Q3 24 | $267.8M | $296.9M | ||
| Q2 24 | $217.4M | $258.0M |
| Q1 26 | — | $308.2M | ||
| Q4 25 | $116.7M | $308.2M | ||
| Q3 25 | $83.7M | $326.6M | ||
| Q2 25 | $113.3M | $209.3M | ||
| Q1 25 | $125.5M | $206.5M | ||
| Q4 24 | $80.1M | $222.6M | ||
| Q3 24 | $120.3M | $237.5M | ||
| Q2 24 | $60.5M | $201.9M |
| Q1 26 | — | 15.2% | ||
| Q4 25 | 7.6% | 15.2% | ||
| Q3 25 | 5.7% | 15.3% | ||
| Q2 25 | 7.8% | 10.1% | ||
| Q1 25 | 8.6% | 10.5% | ||
| Q4 24 | 5.7% | 12.2% | ||
| Q3 24 | 8.9% | 12.4% | ||
| Q2 24 | 4.6% | 10.5% |
| Q1 26 | — | 3.0% | ||
| Q4 25 | 14.8% | 3.0% | ||
| Q3 25 | 12.7% | 2.8% | ||
| Q2 25 | 10.8% | 3.3% | ||
| Q1 25 | 11.2% | 2.8% | ||
| Q4 24 | 14.1% | 3.3% | ||
| Q3 24 | 10.9% | 3.1% | ||
| Q2 24 | 12.1% | 2.9% |
| Q1 26 | — | 1.25× | ||
| Q4 25 | 2.37× | 1.25× | ||
| Q3 25 | 2.14× | 1.15× | ||
| Q2 25 | 1.90× | 0.84× | ||
| Q1 25 | 1.90× | 0.88× | ||
| Q4 24 | 2.31× | 1.08× | ||
| Q3 24 | 2.48× | 1.00× | ||
| Q2 24 | 1.91× | 0.88× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
FAST
| Reportable Segment Aggregation Before Other Operating Segment | $1.8B | 90% |
| Other | $211.2M | 10% |
